{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T22:57:39Z","timestamp":1792623459912,"version":"4.5.0"},"reference-count":68,"publisher":"Oxford University Press (OUP)","issue":"23","funder":[{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["RO1 NS078289"],"award-info":[{"award-number":["RO1 NS078289"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,12,1]]},"DOI":"10.1093\/hmg\/ddx345","type":"journal-article","created":{"date-parts":[[2017,9,4]],"date-time":"2017-09-04T15:10:04Z","timestamp":1504537804000},"page":"4629-4641","source":"Crossref","is-referenced-by-count":31,"title":["Heterozygous loss of TSC2 alters p53 signaling and human stem cell reprogramming"],"prefix":"10.1093","volume":"26","author":[{"given":"Laura C","family":"Armstrong","sequence":"first","affiliation":[{"name":"Division of Pediatric Neurology, Department of Pediatrics, Vanderbilt University Medical Center, D4105 Medical Center North, Nashville, TN 37232, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grant","family":"Westlake","sequence":"additional","affiliation":[{"name":"Division of Pediatric Neurology, Department of Pediatrics, Vanderbilt University Medical Center, D4105 Medical Center North, Nashville, TN 37232, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John P","family":"Snow","sequence":"additional","affiliation":[{"name":"Division of Pediatric Neurology, Department of Pediatrics, Vanderbilt University Medical Center, D4105 Medical Center North, Nashville, TN 37232, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bryan","family":"Cawthon","sequence":"additional","affiliation":[{"name":"Division of Pediatric Neurology, Department of Pediatrics, Vanderbilt University Medical Center, D4105 Medical Center North, Nashville, TN 37232, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Armour","sequence":"additional","affiliation":[{"name":"Division of Pediatric Neurology, Department of Pediatrics, Vanderbilt University Medical Center, D4105 Medical Center North, Nashville, TN 37232, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aaron B","family":"Bowman","sequence":"additional","affiliation":[{"name":"Division of Pediatric Neurology, Department of Pediatrics, Vanderbilt University Medical Center, D4105 Medical Center North, Nashville, TN 37232, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3730-7351","authenticated-orcid":false,"given":"Kevin C","family":"Ess","sequence":"additional","affiliation":[{"name":"Division of Pediatric Neurology, Department of Pediatrics, Vanderbilt University Medical Center, D4105 Medical Center North, Nashville, TN 37232, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2017,9,5]]},"reference":[{"key":"key\n\t\t\t\t20180314005249_ddx345-B1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pediatrneurol.2016.03.015","article-title":"Advances and Future Directions for Tuberous Sclerosis Complex Research: Recommendations From the 2015 Strategic Planning Conference","volume":"60","author":"Sahin","year":"2016","journal-title":"Pediatr. Neurol"},{"key":"key\n\t\t\t\t20180314005249_ddx345-B2","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1016\/0092-8674(93)90618-Z","article-title":"Identification and characterization of the tuberous sclerosis gene on chromosome 16","volume":"75","author":"European","year":"1993","journal-title":"Cell"},{"key":"key\n\t\t\t\t20180314005249_ddx345-B3","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1126\/science.277.5327.805","article-title":"Identification of the tuberous sclerosis gene TSC1 on chromosome 9q34","volume":"277","author":"van Slegtenhorst","year":"1997","journal-title":"Science"},{"key":"key\n\t\t\t\t20180314005249_ddx345-B4","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1056\/NEJMoa063564","article-title":"Sirolimus for angiomyolipoma in tuberous sclerosis complex or lymphangioleiomyomatosis","volume":"358","author":"Bissler","year":"2008","journal-title":"N. Engl. J. Med"},{"key":"key\n\t\t\t\t20180314005249_ddx345-B5","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1016\/j.jpeds.2013.12.053","article-title":"Mammalian target of rapamycin inhibitors for intractable epilepsy and subependymal giant cell astrocytomas in tuberous sclerosis complex","volume":"164","author":"Cardamone","year":"2014","journal-title":"J. Pediatr"},{"key":"key\n\t\t\t\t20180314005249_ddx345-B6","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1002\/ana.20784","article-title":"Rapamycin causes regression of astrocytomas in tuberous sclerosis complex","volume":"59","author":"Franz","year":"2006","journal-title":"Ann. Neurol"},{"key":"key\n\t\t\t\t20180314005249_ddx345-B7","first-page":"CD011272.","article-title":"Rapamycin and rapalogs for tuberous sclerosis complex","volume":"7","author":"Sasongko","year":"2016","journal-title":"Cochrane Database Syst. Rev"},{"key":"key\n\t\t\t\t20180314005249_ddx345-B8","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1056\/NEJMoa1100391","article-title":"Efficacy and safety of sirolimus in lymphangioleiomyomatosis","volume":"364","author":"McCormack","year":"2011","journal-title":"N. Engl. J. Med"},{"key":"key\n\t\t\t\t20180314005249_ddx345-B9","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1086\/321972","article-title":"Survey of somatic mutations in tuberous sclerosis complex (TSC) hamartomas suggests different genetic mechanisms for pathogenesis of TSC lesions","volume":"69","author":"Niida","year":"2001","journal-title":"Am. J. Hum. Genet"},{"key":"key\n\t\t\t\t20180314005249_ddx345-B10","first-page":"400","article-title":"Allelic loss is frequent in tuberous sclerosis kidney lesions but rare in brain lesions","volume":"59","author":"Henske","year":"1996","journal-title":"Am. J. Hum. Genet"},{"key":"key\n\t\t\t\t20180314005249_ddx345-B11","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1111\/j.1750-3639.2010.00416.x","article-title":"Analysis of TSC cortical tubers by deep sequencing of TSC1, TSC2 and KRAS demonstrates that small second-hit mutations in these genes are rare events","volume":"20","author":"Qin","year":"2010","journal-title":"Brain Pathol"},{"key":"key\n\t\t\t\t20180314005249_ddx345-B12","doi-asserted-by":"crossref","first-page":"15816.","DOI":"10.1038\/ncomms15816","article-title":"The genomic landscape of tuberous sclerosis complex","volume":"8","author":"Martin","year":"2017","journal-title":"Nat. Commun"},{"key":"key\n\t\t\t\t20180314005249_ddx345-B13","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1212\/01.wnl.0000252952.62543.20","article-title":"Infantile spasm-associated microencephaly in tuberous sclerosis complex and cortical dysplasia","volume":"68","author":"Chandra","year":"2007","journal-title":"Neurology"},{"key":"key\n\t\t\t\t20180314005249_ddx345-B14","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1017\/S0033291701004561","article-title":"Widespread anatomical abnormalities of grey and white matter structure in tuberous sclerosis","volume":"31","author":"Ridler","year":"2001","journal-title":"Psychol. Med"},{"key":"key\n\t\t\t\t20180314005249_ddx345-B15","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1093\/cercor\/bhs135","article-title":"Impaired language pathways in tuberous sclerosis complex patients with autism spectrum disorders","volume":"23","author":"Lewis","year":"2013","journal-title":"Cereb. Cortex"},{"key":"key\n\t\t\t\t20180314005249_ddx345-B16","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.acra.2011.08.016","article-title":"Loss of white matter microstructural integrity is associated with adverse neurological outcome in tuberous sclerosis complex","volume":"19","author":"Peters","year":"2012","journal-title":"Acad. Radiol"},{"key":"key\n\t\t\t\t20180314005249_ddx345-B17","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1007\/s00401-012-0950-3","article-title":"Cytoarchitectural alterations are widespread in cerebral cortex in tuberous sclerosis complex","volume":"123","author":"Marcotte","year":"2012","journal-title":"Acta Neuropathol"},{"key":"key\n\t\t\t\t20180314005249_ddx345-B18","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.celrep.2016.02.090","article-title":"mTORC1 inhibition corrects neurodevelopmental and synaptic alterations in a human stem cell model of tuberous sclerosis","volume":"15","author":"Costa","year":"2016","journal-title":"Cell Rep"},{"key":"key\n\t\t\t\t20180314005249_ddx345-B19","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/j.stemcr.2017.02.020","article-title":"Abnormal neural progenitor cells differentiated from induced pluripotent stem cells partially mimicked development of TSC2 neurological abnormalities","volume":"8","author":"Li","year":"2017","journal-title":"Stem Cell Rep"},{"key":"key\n\t\t\t\t20180314005249_ddx345-B20","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1093\/cercor\/bhs310","article-title":"Fetal brain mTOR signaling activation in tuberous sclerosis complex","volume":"24","author":"Tsai","year":"2014","journal-title":"Cereb. Cortex"},{"key":"key\n\t\t\t\t20180314005249_ddx345-B21","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1111\/j.1750-3639.2012.00616.x","article-title":"Fetal brain lesions in tuberous sclerosis complex: TORC1 activation and inflammation","volume":"23","author":"Prabowo","year":"2013","journal-title":"Brain Pathol"},{"key":"key\n\t\t\t\t20180314005249_ddx345-B22","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1007\/s004010050691","article-title":"Tuberous sclerosis in a 20-week gestation fetus: immunohistochemical study","volume":"94","author":"Park","year":"1997","journal-title":"Acta Neuropathol"},{"key":"key\n\t\t\t\t20180314005249_ddx345-B23","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1007\/s00247-007-0436-y","article-title":"Value of fetal cerebral MRI in sonographically proven cardiac rhabdomyoma","volume":"37","author":"Muhler","year":"2007","journal-title":"Pediatr. Radiol"},{"key":"key\n\t\t\t\t20180314005249_ddx345-B24","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1038\/nmeth.1591","article-title":"A more efficient method to generate integration-free human iPS cells","volume":"8","author":"Okita","year":"2011","journal-title":"Nat Methods"},{"key":"key\n\t\t\t\t20180314005249_ddx345-B25","doi-asserted-by":"crossref","first-page":"4083","DOI":"10.1074\/jbc.M113.530303","article-title":"p53\/TAp63 and AKT regulate mammalian target of rapamycin complex 1 (mTORC1) signaling through two independent parallel pathways in the presence of DNA damage","volume":"289","author":"Cam","year":"2014","journal-title":"J. Biol. Chem"},{"key":"key\n\t\t\t\t20180314005249_ddx345-B26","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.cell.2008.06.028","article-title":"p53 target genes sestrin1 and sestrin2 connect genotoxic stress and mTOR signaling","volume":"134","author":"Budanov","year":"2008","journal-title":"Cell"},{"key":"key\n\t\t\t\t20180314005249_ddx345-B27","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/S1097-2765(01)00323-9","article-title":"Regulation of PTEN transcription by p53","volume":"8","author":"Stambolic","year":"2001","journal-title":"Mol. Cell"},{"key":"key\n\t\t\t\t20180314005249_ddx345-B28","doi-asserted-by":"crossref","first-page":"8204","DOI":"10.1073\/pnas.0502857102","article-title":"The coordinate regulation of the p53 and mTOR pathways in cells","volume":"102","author":"Feng","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"key":"key\n\t\t\t\t20180314005249_ddx345-B29","doi-asserted-by":"crossref","first-page":"3043","DOI":"10.1158\/0008-5472.CAN-06-4149","article-title":"The regulation of AMPK beta1, TSC2, and PTEN expression by p53: stress, cell and tissue specificity, and the role of these gene products in modulating the IGF-1-AKT-mTOR pathways","volume":"67","author":"Feng","year":"2007","journal-title":"Cancer Res"},{"key":"key\n\t\t\t\t20180314005249_ddx345-B30","doi-asserted-by":"crossref","first-page":"5325","DOI":"10.1038\/sj.onc.1205662","article-title":"p53 activation results in rapid dephosphorylation of the eIF4E-binding protein 4E-BP1, inhibition of ribosomal protein S6 kinase and inhibition of translation initiation","volume":"21","author":"Horton","year":"2002","journal-title":"Oncogene"},{"key":"key\n\t\t\t\t20180314005249_ddx345-B31","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1172\/JCI200317222","article-title":"Loss of Tsc1\/Tsc2 activates mTOR and disrupts PI3K-Akt signaling through downregulation of PDGFR","volume":"112","author":"Zhang","year":"2003","journal-title":"J. Clin. Invest"},{"key":"key\n\t\t\t\t20180314005249_ddx345-B32","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1128\/MCB.06030-11","article-title":"Hypergrowth mTORC1 signals translationally activate the ARF tumor suppressor checkpoint","volume":"32","author":"Miceli","year":"2012","journal-title":"Mol. Cell. Biol"},{"key":"key\n\t\t\t\t20180314005249_ddx345-B33","doi-asserted-by":"crossref","first-page":"85365","DOI":"10.18632\/oncotarget.13378","article-title":"TSC loss distorts DNA replication programme and sensitises cells to genotoxic stress","volume":"7","author":"Pai","year":"2016","journal-title":"Oncotarget"},{"key":"key\n\t\t\t\t20180314005249_ddx345-B34","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1177\/1947601912445376","article-title":"Regulation of PI 3-K, PTEN, p53, and mTOR in Malignant and Benign Tumors Deficient in Tuberin","volume":"2","author":"Habib","year":"2011","journal-title":"Genes Cancer"},{"key":"key\n\t\t\t\t20180314005249_ddx345-B35","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1007\/s004030100259","article-title":"Cells derived from tuberous sclerosis show a prolonged S phase of the cell cycle and increased apoptosis","volume":"293","author":"Wataya-Kaneda","year":"2001","journal-title":"Arch. Dermatol. Res"},{"key":"key\n\t\t\t\t20180314005249_ddx345-B36","doi-asserted-by":"crossref","first-page":"4812","DOI":"10.1038\/sj.emboj.7601900","article-title":"Constitutive mTOR activation in TSC mutants sensitizes cells to energy starvation and genomic damage via p53","volume":"26","author":"Lee","year":"2007","journal-title":"embo J"},{"key":"key\n\t\t\t\t20180314005249_ddx345-B37","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1590\/1678-4685-gmb-2015-0321","article-title":"TSC1 and TSC2 gene mutations and their implications for treatment in Tuberous Sclerosis Complex: a review","volume":"40","author":"Rosset","year":"2017","journal-title":"Genet. Mol. Biol"},{"key":"key\n\t\t\t\t20180314005249_ddx345-B38","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1212\/01.wnl.0000280578.99900.96","article-title":"Overlapping neurologic and cognitive phenotypes in patients with TSC1 or TSC2 mutations","volume":"70","author":"Jansen","year":"2008","journal-title":"Neurology"},{"key":"key\n\t\t\t\t20180314005249_ddx345-B39","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1086\/316951","article-title":"Mutational analysis in a cohort of 224 tuberous sclerosis patients indicates increased severity of TSC2, compared with TSC1, disease in multiple organs","volume":"68","author":"Dabora","year":"2001","journal-title":"Am. J. Hum. Genet"},{"key":"key\n\t\t\t\t20180314005249_ddx345-B40","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1111\/epi.12680","article-title":"Severity of manifestations in tuberous sclerosis complex in relation to genotype","volume":"55","author":"Kothare","year":"2014","journal-title":"Epilepsia"},{"key":"key\n\t\t\t\t20180314005249_ddx345-B41","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1017\/S0012162206001058","article-title":"Tuberous sclerosis complex: clinical features, diagnosis, and prevalence within Northern Ireland","volume":"48","author":"Devlin","year":"2006","journal-title":"Dev. Med. Child Neurol"},{"key":"key\n\t\t\t\t20180314005249_ddx345-B42","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1038\/nbt.3070","article-title":"A comparison of non-integrating reprogramming methods","volume":"33","author":"Schlaeger","year":"2015","journal-title":"Nat. Biotechnol"},{"key":"key\n\t\t\t\t20180314005249_ddx345-B43","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1038\/nature22312","article-title":"Human pluripotent stem cells recurrently acquire and expand dominant negative P53 mutations","volume":"545","author":"Merkle","year":"2017","journal-title":"Nature"},{"key":"key\n\t\t\t\t20180314005249_ddx345-B44","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1038\/nature08311","article-title":"Linking the p53 tumour suppressor pathway to somatic cell reprogramming","volume":"460","author":"Kawamura","year":"2009","journal-title":"Nature"},{"key":"key\n\t\t\t\t20180314005249_ddx345-B45","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1038\/nature08235","article-title":"Suppression of induced pluripotent stem cell generation by the p53-p21 pathway","volume":"460","author":"Hong","year":"2009","journal-title":"Nature"},{"key":"key\n\t\t\t\t20180314005249_ddx345-B46","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1038\/nature08287","article-title":"A p53-mediated DNA damage response limits reprogramming to ensure iPS cell genomic integrity","volume":"460","author":"Marion","year":"2009","journal-title":"Nature"},{"key":"key\n\t\t\t\t20180314005249_ddx345-B47","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1038\/nature08290","article-title":"The Ink4\/Arf locus is a barrier for iPS cell reprogramming","volume":"460","author":"Li","year":"2009","journal-title":"Nature"},{"key":"key\n\t\t\t\t20180314005249_ddx345-B48","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1038\/cdd.2011.120","article-title":"Biological functions of p53 isoforms through evolution: lessons from animal and cellular models","volume":"18","author":"Marcel","year":"2011","journal-title":"Cell Death Differ"},{"key":"key\n\t\t\t\t20180314005249_ddx345-B49","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.stem.2016.01.022","article-title":"CRISPR interference efficiently induces specific and reversible gene silencing in human iPSCs","volume":"18","author":"Mandegar","year":"2016","journal-title":"Cell Stem Cell"},{"key":"key\n\t\t\t\t20180314005249_ddx345-B50","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1126\/science.1157535","article-title":"The Rag GTPases bind raptor and mediate amino acid signaling to mTORC1","volume":"320","author":"Sancak","year":"2008","journal-title":"Science"},{"key":"key\n\t\t\t\t20180314005249_ddx345-B51","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1172\/JCI84262","article-title":"Tuberous sclerosis complex inactivation disrupts melanogenesis via mTORC1 activation","volume":"127","author":"Cao","year":"2017","journal-title":"J. Clin. Invest"},{"key":"key\n\t\t\t\t20180314005249_ddx345-B52","doi-asserted-by":"crossref","first-page":"2994","DOI":"10.1038\/emboj.2010.166","article-title":"S6K1 is a multifaceted regulator of Mdm2 that connects nutrient status and DNA damage response","volume":"29","author":"Lai","year":"2010","journal-title":"embo J"},{"key":"key\n\t\t\t\t20180314005249_ddx345-B53","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.4161\/15384047.2014.955743","article-title":"mTOR inhibitors blunt the p53 response to nucleolar stress by regulating RPL11 and MDM2 levels","volume":"15","author":"Goudarzi","year":"2014","journal-title":"Cancer Biol. Ther"},{"key":"key\n\t\t\t\t20180314005249_ddx345-B54","doi-asserted-by":"crossref","first-page":"21843","DOI":"10.1074\/jbc.M109745200","article-title":"Akt enhances Mdm2-mediated ubiquitination and degradation of p53","volume":"277","author":"Ogawara","year":"2002","journal-title":"J. Biol. Chem"},{"key":"key\n\t\t\t\t20180314005249_ddx345-B55","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1038\/sj.cdd.4400978","article-title":"Mammalian target of rapamycin (mTOR): pro- and anti-apoptotic","volume":"9","author":"Castedo","year":"2002","journal-title":"Cell Death Differ"},{"key":"key\n\t\t\t\t20180314005249_ddx345-B56","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/cdd.2010.82","article-title":"The TSC1 and TSC2 tumor suppressors are required for proper ER stress response and protect cells from ER stress-induced apoptosis","volume":"18","author":"Kang","year":"2011","journal-title":"Cell Death Differ"},{"key":"key\n\t\t\t\t20180314005249_ddx345-B57","doi-asserted-by":"crossref","first-page":"4787","DOI":"10.1038\/sj.onc.1203831","article-title":"Additive effect between NF-kappaB subunits and p53 protein for transcriptional activation of human p53 promoter","volume":"19","author":"Benoit","year":"2000","journal-title":"Oncogene"},{"key":"key\n\t\t\t\t20180314005249_ddx345-B58","doi-asserted-by":"crossref","first-page":"9979","DOI":"10.1073\/pnas.88.22.9979","article-title":"Wild-type p53 can down-modulate the activity of various promoters","volume":"88","author":"Ginsberg","year":"1991","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"key":"key\n\t\t\t\t20180314005249_ddx345-B59","doi-asserted-by":"crossref","first-page":"3415","DOI":"10.1128\/MCB.13.6.3415","article-title":"The tumor suppressor p53 regulates its own transcription","volume":"13","author":"Deffie","year":"1993","journal-title":"Mol. Cell. Biol"},{"key":"key\n\t\t\t\t20180314005249_ddx345-B60","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1089\/dna.1995.14.759","article-title":"Wild-type p53 regulates its own transcription in a cell-type specific manner","volume":"14","author":"Hudson","year":"1995","journal-title":"DNA Cell Biol"},{"key":"key\n\t\t\t\t20180314005249_ddx345-B61","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1016\/j.humpath.2012.03.020","article-title":"Uterine angiosarcoma associated with lymphangioleiomyomatosis in a patient with tuberous sclerosis complex: an autopsy case report with immunohistochemical and genetic analysis","volume":"43","author":"Hayashi","year":"2012","journal-title":"Hum. Pathol"},{"key":"key\n\t\t\t\t20180314005249_ddx345-B62","doi-asserted-by":"crossref","first-page":"336ra361.","DOI":"10.1126\/scitranslmed.aad9370","article-title":"MDM2 inhibition rescues neurogenic and cognitive deficits in a mouse model of fragile X syndrome","volume":"8","author":"Li","year":"2016","journal-title":"Sci. Trans. Med"},{"key":"key\n\t\t\t\t20180314005249_ddx345-B63","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1038\/embor.2009.89","article-title":"The non-apoptotic role of p53 in neuronal biology: enlightening the dark side of the moon","volume":"10","author":"Tedeschi","year":"2009","journal-title":"EMBO Rep"},{"key":"key\n\t\t\t\t20180314005249_ddx345-B64","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1242\/dev.02208","article-title":"p53 suppresses the self-renewal of adult neural stem cells","volume":"133","author":"Meletis","year":"2006","journal-title":"Development"},{"key":"key\n\t\t\t\t20180314005249_ddx345-B65","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1177\/1947601911409736","article-title":"p53 in the CNS: Perspectives on development, stem cells, and cancer","volume":"2","author":"Mendrysa","year":"2011","journal-title":"Genes Cancer"},{"key":"key\n\t\t\t\t20180314005249_ddx345-B66","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1111\/j.1471-4159.2006.03980.x","article-title":"The p53 family in nervous system development and disease","volume":"97","author":"Jacobs","year":"2006","journal-title":"J. Neurochem"},{"key":"key\n\t\t\t\t20180314005249_ddx345-B67","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1038\/nmeth.2019","article-title":"Fiji: an open-source platform for biological-image analysis","volume":"9","author":"Schindelin","year":"2012","journal-title":"Nat. Methods"},{"key":"key\n\t\t\t\t20180314005249_ddx345-B68","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1038\/nbt.2647","article-title":"DNA targeting specificity of RNA-guided Cas9 nucleases","volume":"31","author":"Hsu","year":"2013","journal-title":"Nat. Biotechnol"}],"container-title":["Human Molecular Genetics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/hmg\/article-pdf\/26\/23\/4629\/24339149\/ddx345.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,3,14]],"date-time":"2018-03-14T00:53:19Z","timestamp":1520988799000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/hmg\/article\/26\/23\/4629\/4104402"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9,5]]},"references-count":68,"journal-issue":{"issue":"23","published-online":{"date-parts":[[2017,9,5]]},"published-print":{"date-parts":[[2017,12,1]]}},"URL":"https:\/\/doi.org\/10.1093\/hmg\/ddx345","relation":{},"ISSN":["0964-6906","1460-2083"],"issn-type":[{"value":"0964-6906","type":"print"},{"value":"1460-2083","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2017,12,1]]},"published":{"date-parts":[[2017,9,5]]}}}